上海瑞齊生物科技有限公司作者
Anti-AEG-1 抗體說明書
資料類型 | jpg文件 | 資料大小 | 5038 |
下載次數(shù) | 70 | 資料圖片 | 【點(diǎn)擊查看】 |
上 傳 人 | 上海瑞齊生物科技有限公司 | 需要積分 | 0 |
關(guān) 鍵 詞 | Anti-AEG-1 抗體說明書, Anti-AEG-1 抗體說明書, Anti-AEG-1 抗體 |
- 【資料簡介】
Anti-AEG-1 抗體說明書
Quantity size: 0.2ml (dilute with pH 7.4 0.01 M PBS or diluent of antibody)Background: LYRIC is a type II membrane protein, the precise role of which has yet to be defined. It is expressed in breast and prostate carcinoma and is a potential mediator of lung metastasis. It has also been found in mouse Purkinje neurons and cerebellum. In epithelial cells it is recruited to tight junctions (TJ) during the maturation of the TJ complexes. LYRIC co-localizes with beta-catenin in normal and tumour tissues.Anti-AEG-1 抗體說明書
Specificity: ·anti-AEG-1 is a rabbit monoclonal antibody unconjugated·specific for AEG-1 of human·epitope mapping near the amino terminus of AEG-1 ofHuman· use for western blotting, elisa, immunoprecipitationand immunohistochemistry· Protein A affinity chromatography purification, purity :>95%· Isotype: IgG· mol wt: 82kDaApplication: · Western blotting: 1:100-500· Immunohistochemistry: 1:100-500· ELISA: 1:500-1000· Optimal working dilutions must be determined by the end user.Storage: Store at –20 ºC for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20ºC. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 ºC.Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.Anti-AEG-1 抗體說明書
2024世環(huán)會(huì)【工業(yè)節(jié)能與環(huán)保展】

div6月3日,2024世環(huán)會(huì)【工業(yè)節(jié)能與環(huán)保展】于上海丨國家會(huì)展中[詳細(xì)]
- 凡本網(wǎng)注明"來源:環(huán)保在線"的所有作品,版權(quán)均屬于環(huán)保在線,轉(zhuǎn)載請(qǐng)必須注明環(huán)保在線,http://www.niunang.cn。違反者本網(wǎng)將追究相關(guān)法律責(zé)任。
- 企業(yè)發(fā)布的公司新聞、技術(shù)文章、資料下載等內(nèi)容,如涉及侵權(quán)、違規(guī)遭投訴的,一律由發(fā)布企業(yè)自行承擔(dān)責(zé)任,本網(wǎng)有權(quán)刪除內(nèi)容并追溯責(zé)任。
- 本網(wǎng)轉(zhuǎn)載并注明自其它來源的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點(diǎn)或證實(shí)其內(nèi)容的真實(shí)性,不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個(gè)人從本網(wǎng)轉(zhuǎn)載時(shí),必須保留本網(wǎng)注明的作品來源,并自負(fù)版權(quán)等法律責(zé)任。
- 如涉及作品內(nèi)容、版權(quán)等問題,請(qǐng)?jiān)谧髌钒l(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。